1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CCDC136 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA BRD7 CTRPv2 pan-cancer AAC 0.082 0.01
mRNA TMEM248 CTRPv2 pan-cancer AAC -0.085 0.01
mRNA RHOH CTRPv2 pan-cancer AAC 0.098 0.01
mRNA WDR44 CTRPv2 pan-cancer AAC -0.082 0.01
mRNA CTB-50L17.10 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA CDK8 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA ADRA2B CTRPv2 pan-cancer AAC -0.08 0.01
mRNA RPUSD4 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA LOXL1 CTRPv2 pan-cancer AAC -0.095 0.01
Download CSV